Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
Public ClinicalTrials.gov record NCT05864976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Advancing Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning - a Prospective Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is investigating the use of a computer algorithm to analyze scans of the brain before surgery to predict how a person's tumor will respond to treatment.
Study identification
- NCT ID
- NCT05864976
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 5, 2023
- Primary completion
- Jan 30, 2030
- Completion
- Jan 30, 2030
- Last update posted
- Jun 29, 2026
2023 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63110 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Glioblastoma Multiforme trials
Other public records listing Glioblastoma Multiforme. Sorted by last update posted; newest first. Not a recommendation.
- NCT01837862: A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Active, not recruiting
- NCT04900792: A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma Active, not recruiting
- NCT02177578: Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme Active, not recruiting
- NCT05120284: Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM) Active, not recruiting
- NCT06011109: Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab Recruiting
- NCT05979064: Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05864976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 29, 2026 · Synced Jul 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05864976 live on ClinicalTrials.gov.